Literature DB >> 27960650

First report of HTLV-1 truncated p12 protein in Brazil.

Carolina Rosadas1, Ana C P Vicente2, Louise Zanella2, Mauro J Cabral-Castro1, José M Peralta1, Marzia Puccioni-Sohler1,3.   

Abstract

Entities:  

Keywords:  HTLV-1; mutation; p12

Mesh：

Substances：

Year:  2016        PMID： 27960650      PMCID： PMC5711409          DOI： 10.1080/21505594.2016.1267895

Source DB:  PubMed          Journal:  Virulence        ISSN： 2150-5594            Impact factor:   5.882


× No keyword cloud information.
  28 in total

1.  The MHC class I heavy chain is a common target of the small proteins encoded by the 3' end of HTLV type 1 and HTLV type 2.

Authors:  J M Johnson; J C Mulloy; V Ciminale; J Fullen; C Nicot; G Franchini
Journal:  AIDS Res Hum Retroviruses       Date:  2000-11-01       Impact factor: 2.205

2.  Human T-lymphotropic virus type 1 open reading frame I p12(I) is required for efficient viral infectivity in primary lymphocytes.

Authors:  B Albrecht; N D Collins; M T Burniston; J W Nisbet; L Ratner; P L Green; M D Lairmore
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

Review 3.  Human T-lymphotropic virus proteins and post-translational modification pathways.

Authors:  Carlo Bidoia
Journal:  World J Virol       Date:  2012-08-12

Review 4.  Hijacking the T-cell communication network by the human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p12 and p8 proteins.

Authors:  Nancy Van Prooyen; Vibeke Andresen; Heather Gold; Izabela Bialuk; Cynthia Pise-Masison; Genoveffa Franchini
Journal:  Mol Aspects Med       Date:  2010-07-29

5.  Endoplasmic reticulum and cis-Golgi localization of human T-lymphotropic virus type 1 p12(I): association with calreticulin and calnexin.

Authors:  W Ding; B Albrecht; R Luo; W Zhang; J R Stanley; G C Newbound; M D Lairmore
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  Analyses of HTLV-1 sequences suggest interaction between ORF-I mutations and HAM/TSP outcome.

Authors:  Fernanda Khouri Barreto; Ricardo Khouri; Filipe Ferreira de Almeida Rego; Luciane Amorim Santos; Maria Fernanda de Castro-Amarante; Izabela Bialuk; Cynthia A Pise-Masison; Bernardo Galvão-Castro; Antoine Gessain; Steven Jacobson; Genoveffa Franchini; Luiz Carlos Alcantara
Journal:  Infect Genet Evol       Date:  2016-08-21       Impact factor: 3.342

7.  Proliferation response to interleukin-2 and Jak/Stat activation of T cells immortalized by human T-cell lymphotropic virus type 1 is independent of open reading frame I expression.

Authors:  N D Collins; C D'Souza; B Albrecht; M D Robek; L Ratner; W Ding; P L Green; M D Lairmore
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

8.  Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo.

Authors:  N D Collins; G C Newbound; B Albrecht; J L Beard; L Ratner; M D Lairmore
Journal:  Blood       Date:  1998-06-15       Impact factor: 22.113

9.  Serum profile of T helper 1 and T helper 2 cytokines in hepatitis C virus infected patients.

Authors:  Masoomeh Sofian; Arezoo Aghakhani; Ali Asghar Farazi; Mohammad Banifazl; Ali Eslamifar; Niloofar Rashidi; Akbar Khadem Sadegh; Amitis Ramezani
Journal:  Hepat Mon       Date:  2012-12-29       Impact factor: 0.660

Review 10.  HTLV-1 ORF-I Encoded Proteins and the Regulation of Host Immune Response: Viral Induced Dysregulation of Intracellular Signaling.

Authors:  Carolina Rosadas; Marzia Puccioni-Sohler
Journal:  J Immunol Res       Date:  2015-10-18       Impact factor: 4.818
View more
  2 in total

1.  Absence of accessory genes in a divergent simian T-lymphotropic virus type 1 isolated from a bonnet macaque (Macaca radiata).

Authors:  Philippe V Afonso; Zahra Fagrouch; Martin Deijs; Henk Niphuis; Willy Bogers; Antoine Gessain; Lia van der Hoek; Ernst J Verschoor
Journal:  PLoS Negl Trop Dis       Date:  2019-07-08

Review 2.  Molecular epidemiology, genetic variability and evolution of HTLV-1 with special emphasis on African genotypes.

Authors:  Philippe V Afonso; Olivier Cassar; Antoine Gessain
Journal:  Retrovirology       Date:  2019-12-16       Impact factor: 4.602
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.